Human interferon-a A/D (BglII) (IFN-a A/D) and mouse interferon-y (IFN-y) are shown to induce xanthine dehydrogenase (XD) mRNA in L929 fibroblastic cells. XD mRNA accumulation after IFN-a A/D treatment is relatively fast, being already evident after 4 h and reaching its maximum after 24 h. IFN-a A/D is active in inducing XD mRNA at 0.1 unit/ml and it is maximally active at 103 units/ml. The half-life of the XD message is unaffected-by IFN-c A/D treatment, whereas the transcriptional activity of the XD gene and the concentrations of XD heterogeneous nuclear RNA are increased by 2-and 6-fold respectively. The effect of IFN-a A/D on XD mRNA is insensitive to cycloheximide, suggesting that protein synthesis de novo is not required. Experiments conducted with specific inhibitors suggest that protein kinase C, cyclic AMP and arachidonic acid metabolites derived from lipoxygenase or cycloxygenase do not act as second-messenger molecules in the induction of XD mRNA by IFN-a A/D. XD mRNA is also induced in NIH3T3 fibroblastic cells, but not in F9 teratocarcinoma or B16 melanoma cells after treatment with IFN-a A/D. NIH3T3 are the only cells so far tested that have detectable XD and xanthine oxidase activities under basal conditions and after IFN-a A/D treatment, although their responsiveness to the cytokine is much less than that observed in L929 cells.
INTRODUCTION
Interferons (IFNs) have pleiotropic effects on various cell types: they induce an antiviral state, they generally inhibit the proliferation of both normal and tumour cells and are involved in the complex network of cytokines that regulates the haematopoietic system (Isaac & Lindenmann, 1957; Lengyel, 1982; Kirchner & Shellekens, 1984; Pestka et al., 1987 ). There are three major antigenic groups of IFNs, i.e. a, /8 and y. The former two are also known as type-I IFNs whereas the latter is known as type II (Pestka et al., 1987) . IFNs modulate the expression of more than thirty genes in various cell types (Staeheli, 1990) , and most of these genes are of unknown function.
IFNs-a/,8 and IFN-y act through two distinct membrane receptors (Aguet, 1991) and regulate the expression of different but partly overlapping subsets of genes (Weil et al., 1983; Benech et al., 1985a; Boss & Strominger, 1986; Reich et al., 1987; Luster & Ravetch, 1987; Porter et al., 1988; Reid et al., 1989) . Recombinant human interferon-a A/D (BglII) (IFN-a A/D), a type-I IFN that crosses animal species barriers, is capable of inducing mouse xanthine oxidase (EC 1.1.3.22; XO) and xanthine dehydrogenase (EC 1.1.1.204; XD) activities in vivo (Ghezzi et al., 1984 (Ghezzi et al., , 1985 . The two enzyme activities are involved in the intracellular catabolism of purines and carry out the same metabolic steps, i.e. transformation of hypoxanthine into xanthine and xanthine into uric acid. However, whereas XO transfers the reducing equivalents generated by the enzyme reactions to molecular oxygen, XD transfers them to NADI. The two enzyme forms are the products of a single gene (the gene and the transcript coding for XD and XO are referred to as the XD gene and XD transcript respectively throughout this paper) and they are interconvertible in several experimental conditions both in vitro and in vivo (Della Corte & Stirpe, 1968 , 1972 .
XO activity has been suggested to play a role in the hepatotoxicity observed in vivo after IFN treatment, probably because of its capacity to produce highly reactive superoxide anions. In fact, IFN-a A/D as well as bacterial lipopolysaccharide (LPS) and polyriboinosinic:polyribocytidylic acid (poly I/C) induce XO activity and depress cytochrome P-450 concentrations in mouse liver (Ghezzi et al., 1984 (Ghezzi et al., , 1985 Carpani et al., 1990) . The effect of IFN in vivo is prevented by pretreatment of animals with allopurinol and N-acetylcysteine, a specific inhibitor of XO and a scavenger of oxygen radicals respectively (Ghezzi et al., 1985) . It is also possible that XO (or XD) is involved in the antiviral, antiproliferative or immunomodulatory activity of IFNs. The cDNA coding for mouse XD has been cloned in our laboratory, allowing us to demonstrate that the induction of XO activity in the liver by IFN is primarily the consequence of an increased accumulation of XD mRNA and it is not due to an increased conversion of XD into XO (Terao et al., 1992) . To study in more detail the molecular mechanisms underlying the induction of the expression of the XD gene, experiments were carried out using L929 fibroblastic cells, because they are widely used in vitro as a model system for the antiviral effect of IFNs. The data presented in this report suggest that the XD gene represents a primary target of both type-I and type-II IFNs. Furthermore the increased accumulation of the XD transcript after treatment with type-I IFNs is the result of an induction in the transcriptional rate of the gene as well as early posttranscriptional nuclear events. Northern-blot analysis Total RNA was prepared from cells according to a modification of the guanidinium isothiocyanate/caesium chloride method (Rambaldi et al., 1987) . Nuclear RNA was extracted from cell nuclei isolated by sucrose-gradient centrifugation (Marzluff & Huang, 1984) . The RNA (10 or 15 ,ug) was then fractionated on a 1.20% agarose gel with 6 % formaldehyde and blotted on to synthetic nylon membranes (GeneScreen Plus; New England Nuclear, Boston, MA, U.S.A.). These membranes were hybridized with XDgtl, a 1.8 kb EcoRI fragment of mouse liver XD cDNA (Terao et al., 1992) , mouse a-actin cDNA (Minty et al., 1981) or histone H2a cDNA (Seiler-Tuyns & Birnstiel, 1981) . The probes were labelled to a specific radioactivity of 1 x 109-2 x 109 c.p.m./,ug by using hexanucleotide primers and [32P]dCTP (Amersham, Little Chalfont, Bucks., U.K.) (Feinberg & Vogelstein, 1983) . Hybridization was performed at 60°C overnight in a solution containing 1 M-NaCl, 1 % (w/v) SDS, 10 % (w/v) dextran sulphate (Sigma), 100,ug of salmon sperm DNA/ml (Boehringer, Mannheim, Germany) and 1 x 106-2 x 106 c.p.m. of radiolabelled probe/ml. The membranes were washed twice with 2 x SSC/1 0% (w/v) SDS (1 x SSC being 0.15 M-NaCl/0.015 M-sodium citrate, pH 7.0) for 1 h at 65°C and 0.1 x SSC for 30 min at room temperature. The membranes were dried and exposed to Kodak-XOmat X-ray films with two intensifying screens (du Pont Cronex, du Pont de Nemours, Bad Homburg, Germany) at -70 'C.
MATERIALS AND METHODS
Nuclear transcription run-on assay Nuclear transcription run-on assays were performed as described by Greenberg & Ziff (1984) with some modifications. Briefly, nuclei were prepared by lysing cells (approx. 1 x 107) with 4 ml of lysis buffer [0.5 % (w/v) Nonidet P40/0.01 mMNaCl/0.003 M-MgCl2/0.01 M-Tris, pH 7.4]. After being washed with ice-cold lysis buffer, nuclei were resuspended in glycerol buffer [40 % (w/v) mouse liver XD cDNA (XDgtl; Terao et al., 1992) , histone H2a cDNA (Hatch & Bonner, 1988 ) and a-actin cDNA (Minty et al., 1981) .
Autoradiograms of both Northern-blot analysis and nuclear run-on assays were quantified by laser-scanning densitometry with a laser beam densitometer (300 A computing densitometer Fast Scan; Molecular Dynamics, Sunnyvale, CA, U.S.A.).
Measurement of XD and XO activities
Cell monolayers (approx. 4 x 106 cells) from a 25 cm2 dish were washed twice with 0.9% NaCl, harvested using a 'rubber policeman', and pelleted by centrifugation at 1500 rev./min. Cells were resuspended in 60 ,ul of homogenization buffer (0.05 MTris/HCl, pH 7.8) and disrupted by sonication using a Branson sonifier at its maximum setting, twice, for 5 s at 4 'C. The total homogenate (3 ,ul) was used for XD and XO assays, 14C]hypoxanthine (Amersham) as substrate by the procedure of Reiners et al. (1987) . XO and XD activities were normalized for the content of protein in the sample. Proteins were measured by the method of Bradford (1976) with BSA as standard. One unit is defined as the amount of enzyme capable of transforming 1 nmol of substrate into xanthine and uric acid in 1 min at 37 'C.
RESULTS
L929 fibroblastic cells were chosen to study the molecular mechanisms underlying the induction of the XD mRNA by interferons (IFNs) in vitro, because these cells are widely used to assay the antiviral effect of type-I IFNs and because they are known to express both IFN-a/,8 and IFN-y receptors. Fig. 1(a) shows that IFN-a A/D is capable of inducing XD mRNA [the size of this transcript is similar to that of ribosomal 28S RNA, as expected from our previous work (Terao et al., 1992) ] after 18 h of incubation, whereas the concentrations of a-actin mRNA are not changed relative to control. The induction of the specific transcript is variable and ranges between 7-and 13-fold according to the experiment. Treatment of L929 cells with LPS or poly(I/C), two inducers of IFN activity, does not result in the induction of XD mRNA, contrary to what is observed in vivo (Terao et al., 1992) . The production of IFN by L929 cells is thus probably too low to determine activation of the expression of the XD gene in these experimental conditions or these cells do not express receptors for LPS or double-stranded RNA. As shown in Fig cDNA. This cDNA hybridizes with a low-and a high-M, mRNA species (Benech et al., 1985b) . Only data regarding the low-Mr oligoAS mRNA, migrating as a 1600-nucleotide-long transcript, are presented throughout this report, since the higher-M, mRNA behaves in a similar manner. The induction of oligoAS is always parallel with that of XD mRNA even though the latter transcript is much more sensitive to the inducing effect of IFN-y in the experimental conditions presented in Fig. l(b) .
As shown in Fig. 2(a) , the time-course for the induction of XD mRNA by IFN-cc A/D is quite rapid, since an increase in the levels of the transcript is already evident after 4 h and reaches its maximum between 24 and 48 h. Moreover, the induction of XD mRNA is observed for all the concentrations of the cytokine used, as shown in Fig. 2(b) . The maximal induction is, however, attained between 103 and 105 units/ml, which is similar to that observed for oligoAS. A similar time-frame is again observed for . . , 6 . , . | | < S ; S E -A c t i n Since the inhibitory effect of actinomycin D suggests a transcriptional mechanism, nuclear run-on experiments in the absence and presence of IFN-a A/D were performed using XD, oligoAS, actin and histone H2a cDNAs, and the results are shown in Fig.  4 . As expected, the transcriptional activity of the genes for actin and histone H2a is not affected by treatment with IFN-a A/D at all the time-points tested, whereas the cytokine induces the transcriptional activity of the XD gene 2.4-fold by 2 h. Furthermore, nuclear run-on signals for XD remain constantly elevated at least up to 6 h (by 2-2.5-fold at all the time-points tested) after IFN-a A/D treatment. The transcriptional activity of the oligoAS gene is also increased with a similar time-frame. However, owing to its lower level of transcription under basal conditions, the induction of the run-on signal after IFN-a A/D treatment is quantitatively more evident (at least 10-fold). Runon experiments were repeated twice with consistent results. The elevation in the transcriptional activity for both oligoAS and XD genes precedes the increase in the respective mRNA accumulation (compare Fig. 4 with Fig. 2a) .
To determine whether the IFN-a A/D-mediated effects on XD mRNA were due to alterations in the stability of the XD message, we examined the effects of the cytokine in the presence of actinomycin D. As shown in Fig. 5 (Schneck et al., 1982; Nagata et al., 1984; Reich & Pfeffer, 1990) . The results shown in Fig. 7 (a) demonstrate that protein kinase C does not play any role in the induction of XD mRNA by IFN-a A/D. In fact, phorbol 12-myristate 13-acetate, a general direct activator of protein kinase C is neither capable of inducing the XD transcript nor does it synergize with the cytokine in this respect. Moreover, maximally active concentrations (Reich & Pfeffer, 1990 ) of two non-specific inhibitors of protein kinase C, i.e. staurosporine and (Fig. 7b) . Furthermore, incubation of L929 cells for 18 h with indomethacin or nordihydroguaiaretic acid, which are inhibitors of the cycloxygenase-and the lipoxygenase-mediated metabolism of arachidonic acid respectively, do not have any effect on the induction of XD mRNA by IFN-ac A/D (results not shown).
To investigate whether the induction of XD mRNA by IFN is peculiar to L929 cells and if it is always parallel with the induction of the oligoAS message, experiments were performed on other cell lines. B16 melanoma cells were selected because IFN-ac is used in the treatment of melanomas (Gresser, 1991) . F9 teratocarcinoma cells were chosen because they contain an adenovirus EIA-like activity (Imperiale et al., 1984) and it is known that adenoviruses counteract some of the effects of IFNs through the action of similar molecules (Ackrill et al., 1991) . NIH3T3 cells are of interest because, like L929 cells, they represent a fibroblastic cell line. Fig. 8 demonstrates that the induction of XD transcript is not limited to L929 cells but it is observed also in NIH3T3 cells, even though this cell line shows a basal level of XD transcript that is higher than that observed in L929 cells and it is less responsive to the induction of the XD transcript by IFN (about 3-fold relative to control conditions). B16 melanoma cells as well as F9 teratocarcinoma cells show no increase in XD transcript after treatment with 103 units of IFN-a A/D/ml. This effect is not due to a lack of IFN receptors on their plasma membrane since oligoAS mRNA is increased in both cell lines after treatment with the cytokine.
Despite their usefulness as an experimental model in the study of the regulation of XD transcript by IFNs, L929 cells are devoid of XD and XO activities in both the absence and presence of the cytokine. In fact, experiments performed using a range of IFNa A/D concentrations from 0.1 to 105 units/ml and a time-frame of treatment from 4 to 72 h show XD and XO activities below the limit of detection of the sensitive radiometric enzyme assay used (Reiners et al., 1987) (Gianni' et al., 1991; Glesne et al., 1991) . Early post-transcriptional nuclear events seem to play a major role in the observed induction of the mature transcript, as suggested by the Northern-blot data obtained after extraction of RNA from nuclear fractions. Despite the low levels of increase in the transcriptional rate of the XD gene by IFN-a A/D, the data presented are consistent with the presence of an IFN-stimulated responsive element (ISRE) (Cohen et al., 1988; Rutherford et al., 1988) somewhere within the XD gene. The ISRE would allow the regulation of the XD gene by type-I IFNs as a consequence of its interaction with one of the transcriptional trans-activating factors that are known to be under the control of this family of cytokines . More specifically, the induction of the transcriptional activity of the XD gene might be due to the activation of the ISGF3 transcriptional complex (E complex according to another nomenclature) Levy et al., 1989) . ISGF3 is present under basal conditions in the cytoplasm as an inactive complex (Levy et al., 1989) . Activation is triggered by as yet unidentified post-translational mechanisms by IFN and it is followed by subsequent export to the nucleus where it binds to the ISRE (Hannigan & Williams, 1991 The biochemical signals that stand between the interaction of type-I IFNs with their receptor and the activation of the transcription of the genes under the control of these cytokines are still unknown.
Protein kinase C has been implicated as a mediator of the growth-suppressive signals of IFNs in haematopoietic cells (Fan et al., 1988; Reich & Pfeffer, 1990; Tiefenbrun & Kimchi, 1991) . Arachidonic acid metabolites (Hannigan & Williams, 1991) and the cyclic AMP-dependent protein kinase system (Nagata et al., 1984 ) have also been implicated as possible second-messenger molecules of IFN-mediated effects. However, our data are against any involvement of protein kinase C, cyclic AMP or arachidonic acid metabolism (via either the lipoxygenase or the cycloxygenase system) in the induction of XD mRNA in L929 cells. Reactive oxygen intermediates have been proposed as possible second messengers in the activation of the transcriptional factor NFkB (Schreck et al., 1991) . To test a possible role for these oxygen species in the induction of XD mRNA by IFN-oc A/D, experiments using various concentrations of N-acetylcysteine, a known scavenger of free radicals, were performed. All the experiments produced negative results (not shown).
Since the XD mRNA has been shown to be under the direct control of IFNs in vivo (Terao et al., 1992) , it is important to compare its behaviour with that of genes that are classically considered as markers for the biological activity of these cytokines. For Terao, G. Cazzaniga & E. Garattini, unpublished work) . At present, the lack of specific antibodies recognizing mouse XD prevents us determining whether the block in the expression of XD activity is a translational or post-translational event. The only cells (among the limited number of cell lines so far tested) that express measurable XD and XO activity are NIH3T3. These cells demonstrate XD and XO activities that are easily measured in both control and IFN-stimulated conditions. However, this cell line responds poorly to IFN-a A/D treatment and cannot be used to study the molecular mechanisms underlying the induction of XD mRNA by the cytokine. Furthermore, NIH3T3 is not commonly used as a target cell for the biological effects of IFNs. Whatever mechanism is responsible for the lack of expression of XD and XO activities in L929 and other cell lines under basal as well as stimulated conditions, it is clear that this fact rules out a possible involvement of this protein in the antiviral response induced by IFNs in L929 cells. It is yet to be established whether this protein plays any role in the antiproliferative or immunomodulatory activity of IFNs. Further experiments are required to clarify these points.
